Merrimack Pharmaceuticals
(NASDAQ:MACK)
$14.72
-0.02[-0.14%]
At close: Mar 18
$14.72
0[0.00%]
After Hours: 4:28PM EDT

GET A REPORT ON MACK SENT RIGHT TO YOUR INBOX

25%
Overview Rating
Speculative
Technicals Analysis
66
0100
Financials Analysis
0
0100
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Ratings
Strong Buy
Buy
Hold
Sell
Strong Sell
About Merrimack Pharmaceuticals Inc
Sector
Health Care
Industry
Biotechnology
Merrimack Pharmaceuticals Inc is a biotechnology company that discovers, develops, and commercialize...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
MACK
IPHA

FAQ

Q

How do I buy Merrimack Pharmaceuticals (MACK) stock?

A

You can purchase shares of Merrimack Pharmaceuticals (NASDAQ: MACK) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Merrimack Pharmaceuticals's (MACK) competitors?

Q

What is the target price for Merrimack Pharmaceuticals (MACK) stock?

A

The latest price target for Merrimack Pharmaceuticals (NASDAQ: MACK) was reported by Baird on Monday, October 22, 2018. The analyst firm set a price target for 4.00 expecting MACK to fall to within 12 months (a possible -72.83% downside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Merrimack Pharmaceuticals (MACK)?

A

The stock price for Merrimack Pharmaceuticals (NASDAQ: MACK) is $14.72 last updated March 18, 2024 at 4:28 PM EDT.

Q

Does Merrimack Pharmaceuticals (MACK) pay a dividend?

A

A quarterly cash dividend of $0.50 per share of Class A Common Stock. The quarterly cash dividend was payable on December 23, 2019 to stockholders of record on December 13, 2019.

Q

When is Merrimack Pharmaceuticals (NASDAQ:MACK) reporting earnings?

A

Merrimack Pharmaceuticals’s Q1 earnings are confirmed for Thursday, May 2, 2024.

Q

Is Merrimack Pharmaceuticals (MACK) going to split?

A

There is no upcoming split for Merrimack Pharmaceuticals.

Q

What sector and industry does Merrimack Pharmaceuticals (MACK) operate in?

A

Merrimack Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch